Gilead Sciences: Harvoni Launch ‘Off to a Strong Start’
March 04, 2015 at 10:53 AM EST
Barclays’ Geoff Meacham and Marck Purcell believe “survey data from ImpactRx highlights bullish trends for Gilead Sciences (GILD).” They explain: Sipa USA/Associated Press Survey data from ImpactRx highlights bullish trends for Gilead. The Harvoni launch is off to a strong start and clarity on discounting has shifted the Street focus to volume/market share trends between [...]